| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8b201ffd2a1990c952659e9c7e189df |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-1132 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-1128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0619
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0208 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 |
| filingDate |
2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40e0dc37687ecdf16d6f7a7254bed823
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03407ee8bd2af7f5f325e35d8777b502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56fb7c7abe021f2d4f0024817cb2e776 |
| publicationDate |
2020-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111629691-A |
| titleOfInvention |
Apparatus and method for creating a fluidic containment field for administering therapeutic agents to nerves |
| abstract |
Severed nerves can be surgically reconnected and severed axons fused via sequential administration of the solution. The solution may include a prefill solution comprising methylene blue-containing Ca2 +-free salt solution, a fusion solution comprising about 50% (w/w) PEG, and a sealing solution comprising a Ca2 + -containing salt solution. The PEG fusion solution can be applied to a neurotherapy device configured to isolate a damaged segment of a nerve. The device may include a containment chamber for creating a fluid containment field around the anastomosis. The device may have slits, slots and/or holes in opposing end walls of the device designed to receive nerves. The apparatus may have an open bath configuration, or may include separable lower and upper bodies to form a closed bath configuration. The device may include one or more fluid ports in fluid communication with the containment chamber for introduction and/or removal of fluid. |
| priorityDate |
2017-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |